Talk:Joshua Prager (doctor)

Latest comment: 7 years ago by Jytdog in topic unsourced 1

Untitled edit

whoa there tiger easy on the unsubstantiated statements Kato

wants to be renamed edit

...wants to be renamed to Joshua P. Prager, which is how he's cited in many places including https://www.neuromodulation.org/Portals/0/Gallery/Publications/Newsletters/nansnews08_spring.pdf — Preceding unsigned comment added by Vonfraginoff (talkcontribs) 03:49, 4 May 2016 (UTC)Reply

unsourced 1 edit

the following sections are unsourced. moving here til they can be sourced per VERIFY and BLP

from lead

He served on the Board of Directors of the International Neuromodulation Society (INS). He was founder of the Neuromodulation Therapy Access Coalition (NTAC), a coalition of national and international physician organizations and other stakeholders dedicated to insuring patient access to neuromodulation. He serves as Liaison Board Member between NANS and the INS.

from career section

After undergraduate and graduate studies in Stony Brook University and Harvard University, where he served as the President of the Harvard Graduate Student Council, Prager graduated from Stanford University with M.D. as well as M.S. in Management/Health Services Research in 1981. He completed training in internal medicine at UCLA before completing training in anesthesiology at Massachusetts General Hospital (MGH) at Harvard Medical School and Stanford University School of Medicine. He has served on the full-time faculty at MGH at Harvard Medical School and at UCLA School of Medicine where he served as Director of the UCLA Pain Medicine Center. He is Board Certified in Internal Medicine, Anesthesiology and Pain Medicine.

Current and recent public service

In 2011,Prager completed, two terms, six years of service on the Medical Evidence Evaluation Advisory Committee (MEEAC) , a group appointed by the Governor of California to develop treatment guidelines for medical care of the injured worker. He is a Medical Expert for the Medical Board of California, the California Attorney General and the District Attorney of the County of Los Angeles. He has advised Medicare on the local level as reimbursement expert and as a member of the Carrier Advisory Committee (CAC) and currently holds an appointment on the national level on the CAC..

Public service has been an important aspect of Prager's career. He helped establish or reorganize several inner-city health centers, provided volunteer internal medicine care at Haight Ashbury Free Clinics, and provided volunteer anesthesia for children in the developing world who need corrective surgeries for congenital anomalies.[citation needed] He has held numerous positions with other medical organizations. Most recently,[when?] he organized the first meeting of a coalition of pain organizations and all three manufacturers of spinal cord stimulator systems to collaborate on issues of patient access and reimbursement for neuromodulatory procedures.

Awards and distinctions
  • Bounty of Hope Award, Reflex Sympathetic Dystrophy Society of America (RSDSA) for Patient Care and contributions to the RSD community. (2007)
  • California Society of Anesthesiologists (CSA), for contributions to the education of anesthesiologists. (2007)
  • Decade of Pain Lecture, American Academy of Pain Medicine. (2007)
  • Texas Pain Society, Samuel Hassenbusch Lecture. (2009)
  • Lifetime Achievement Award, Presented at the 16th Annual Meeting of the North American Neuromodulation Society (2012)
  • Award for Dedication and Contributions to the field of Neurmodulation at the Scientific Meeting of the International Neuromodulation Society, Berlin, Germany (2013)
  • UCLA Department of Anesthesiology, Outstanding teaching and contributions to the Pain Fellowship. (2002 and 2003)

-- Jytdog (talk) 23:34, 14 May 2016 (UTC)Reply

Needs weeding down edit

per WP:NOTCV

Select articles
  • Prager JP (2010). "What does the mechanism of spinal cord stimulation tell us about complex regional pain syndrome". Pain Med. 11 (8): 1278–1283. doi:10.1111/j.1526-4637.2010.00915.x. PMID 20704677.
  • Prager JPP, Aprill C (2008). "Complications Related to Sedation and Anesthesia for Interventional Pain Therapies". Pain Med. 9 (S!): S121–S127. doi:10.1111/j.1526-4637.2008.00448.x.
  • Prager JP (2002). "Neuraxial Medication Delivery: The Development and Maturity of a Concept for Treating Chronic Pain of Spinal Origin". Spine. 27 (22): 2593–2605. doi:10.1097/00007632-200211150-00037. PMID 12435999.
  • Oakley JC, Prager JP (2002). "Spinal cord stimulation: mechanisms of action". Spine. 27 (22): 2574–83. doi:10.1097/00007632-200211150-00034. PMID 12435996.
  • Prager JP, Jacobs M (2001). "Evaluation of Patients for Implantable Pain Modalities: Medical and Behavioral Assessment". Clin J Pain. 17 (3): 206–214. doi:10.1097/00002508-200109000-00004. PMID 11587110.
  • Prager JP (1996). "Invasive modalities for the diagnosis and treatment of pain in the elderly". Clin Geriatr Med. 12 (3): 549–61. PMID 8853945.
  • Prager JP, DeSalles A, Wilkinson A, Jacobs M, Csete M (1995). "Loin pain hematuria syndrome: pain relief with intrathecal morphine". Am J Kidney Dis. 25 (4): 629–31. doi:10.1016/0272-6386(95)90135-3. PMID 7702062.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Prager J, Deer, T, Levy R, Bruel B, Buchser E, Caraway D, Cousins M, Jacobs M, McGlothlen G, Rauck R, Staats P, Stearns L (2014). "Best practices for Intrathecal Drug Delivery for Pain". Neuromodulation. 17 (4): 354–372. doi:10.1111/ner.12146.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Connolly SB, Prager JP, Harden RN (2015). "A Systematic Review of Ketamine for Complex Regional Pain Syndrome". Pain Medicine. 16 (5): 943–969. doi:10.1111/pme.12675.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • O'Brien SL, Pangarkar S, Prager JP (2014). "The Use of Ketamine in Neuropathic Pain". Current Physical Medicine and Rehabilitation Reports. 2 (5): 128–145.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Baron R, Backonja MM, Eldridge P, Levy R, Vissers K, Attal N, Buchser E, Gruccu G, De Andrés J, Hansson P, Jacobs M, Loeser JD, Prager JP, Hicks MS, Regnault A, Van den Abeele C, Taylor RS (2013). "Refractory Chronic Pain Screening Tool (RCPST): A Feasibility Study to Assess Practicality and Validity of Identifying Potential Neurostimulation Candidates". Pain Medicine. 15 (2): 281–291. doi:10.1111/pme.12272.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, Caraway D, Cousins M, De Andrés J, Diwan S, Erdek M, Grigsby E, Huntoon M, Jacobs MS, Kim P, Kumar K, Leong M, Liem L, McDowell GC, Panchal S, Rauck R, Saulino M, Sitzman BT, Staats P, , Stanton-Hicks M, Stearns L, Wallace M, Willis KD, Witt W, Yaksh T, Mekhail N (2012). "Polyanalgesic Consensus Conference 2012: Recommendations for the Management of Pain by Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel". Neuromodulation. 15 (5): 436–466. doi:10.1111/j.1525-1403.2012.00476.x.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, Caraway D, Cousins M, De Andrés J, Diwan S, Erdek M, Grigsby E, Huntoon M, Jacobs MS, Kim P, Kumar K, Leong M, Liem L, McDowell GC, Panchal S, Rauck R, Saulino M, Sitzman BT, Staats P, Stanton-Hicks M, Stearns L, Wallace M, Willis KD, Witt W, Yaksh T, Mekhail N (2012). "Polyanalgesic Consensus Conference—2012: Recommendations on Trialing for Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel". Neuromodulation. 15 (5): 420–435. doi:10.1111/j.1525-1403.2012.00450.x.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Deer TR, Prager J, Levy R, Burton A, Buchser E, Caraway D, Cousins M, De Andrés J, Diwan S, Erdek M, Grigsby E, Huntoon M, Jacobs MS, Kim P, Kumar K, Leong M, Liem L, McDowell GC, Panchal SJ, Rauck R, Saulino M, Staats P, Stanton-Hicks M, Stearns L, Sitzman BT, Wallace M, Willis KD, Witt W, Yaksh T, Mekhail N (2012). "Polyanalgesic Consensus Conference—2012: Recommendations on Trialing for Intrathecal (Intraspinal) Drug Delivery: Report of an Interdisciplinary Expert Panel". Neuromodulation. 15 (5): 436–466.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Deer TR, Prager J, Levy R, Rathmell J, Buchser E, Burton A, Caraway D, Cousins M, De Andrés J, Diwan S, Erdek M, Grigsby E, Huntoon M, Jacobs MS, Kim P, Kumar K, Leong M, Liem L, McDowell GC, Panchal S, Rauck R, Saulino M, Sitzman BT, Staats P, Stanton-Hicks M, Stearns L, Wallace M, Willis KD, Witt W, Yaksh T, Mekhail N (2012). "Polyanalgesic Consensus Conference—2012: Consensus on Diagnosis, Detection, and Treatment of Catheter-Tip Granulomas (Inflammatory Masses)". Neuromodulation. 15 (5): 483–495. doi:10.1111/j.1525-1403.2012.00449.x. PMID 22494332.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  • Guillemette S, Witzke S, Leier J, Hinnenthal J, Prager JP (2013). "Medical Cost Impact of Intrathecal DrugDelivery for Noncancer Pain". Pain Medicine. 14 (4): 504–515. doi:10.1111/j.1526-4637.2013.01398.x. PMID 23480485.{{cite journal}}: CS1 maint: multiple names: authors list (link)

- Jytdog (talk) 23:33, 14 May 2016 (UTC)Reply